Could Hexo Corp (TSX:HEXO) Be in Trouble With Regulators As Well?

A recent report by a short-seller suggests that Hexo Corp (TSX:HEXO)(NYSE:HEXO) might be the next cannabis stock to run into issues with Health Canada.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There’s a lot of fear in the cannabis industry in the wake of the CannTrust Holdings scandal. Issues relating to illegal growing there came out of nowhere and sent the stock crashing in just a matter of days.

Then came the news that cannabis giant Curaleaf Holdings in the U.S. was also getting into trouble with the Food and Drug Administration for making some aggressive claims.

These issues have caused a great deal of panic in the industry, and many pot stocks have been struggling over the past month as a result.

One company that’s recently been the target of one short-seller is Hexo Corp (TSX:HEXO)(NYSE:HEXO).

A recent report from The Friendly Bear claims that promotions run by the cannabis operator on Snapchat were “aggressive,” suggesting that they could also run afoul with Health Canada. Using Snapchat is also popular among kids, and if true, that could lead to problems for Hexo.

Could Hexo be the next CannTrust?

The short-seller believes that Hexo could follow in the footsteps of CannTrust, losing a significant amount of its value as a result of the infraction.

However, it should be noted that what CannTrust is accused of doing is illegally growing marijuana, which is on a much different scale than simply promoting their products too aggressively or through the wrong channels.

In Hexo’s situation, products wouldn’t have to be held back to be tested to ensure they’re in compliance with regulations. The company also isn’t being alleged to have misled regulators with respect to how much cannabis it is producing and putting up fake walls to conceal its operations.

Compared to the CannTrust scandal, Hexo is a drop in the bucket. After all, advertisers pushing the limits happens in many industries, not just cannabis; suggesting that Hexo might see a similar drop in share price might therefore be an exaggeration, to say the least.

Health Canada hasn’t indicated the existence of any problems involving Hexo. While it can be unnerving for investors of Hexo, ultimately this is just speculation by a short-seller.

We don’t know whether these claims are valid, and so any concerns surrounding the company may be all for naught. The problem, however, is that if there was confirmation that Hexo was in violation of rules relating to advertising, the stock could go into a free fall very quickly.

Bottom line

It’s a very risky time to be a cannabis investor. Everyone is on the lookout for which company could be the next one to run into regulatory issues, which means that even claims made by a short-seller could send investors into a panic.

The problem is that if investors don’t act on the claims early enough, they could suffer more significant losses if the violations are confirmed to be true. However, if prove to be unfounded, the stock could get a big boost in price.

There’s no way to know for sure — which is making investing in cannabis stocks even riskier today.

Should you invest $1,000 in Hexo Corp right now?

Before you buy stock in Hexo Corp, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Hexo Corp wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »